Physician profile
John Sparrow
NPI 1245208719
$1,197.14
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $185 · 2021: $233 · 2022: $419 · 2023: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $719.50 | 2020-2022 | |
| Abbvie INC. | $168.67 | 2023 | Natrelle Saline-Filled Breast Implants |
| Kerecis Limited | $103.50 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Rti Surgical, INC | $69.07 | 2021 | |
| Janssen Biotech, INC. | $51.13 | 2022-2023 | Tremfya, Simponi Aria, Remicade |
| Sientra, INC. | $30.14 | 2020 | |
| Endo Pharmaceuticals INC. | $19.25 | 2023 | Xiaflex |
| Smith+Nephew, INC. | $18.17 | 2023 | Renasys Go V2 Home |
| Kowa Pharmaceuticals America, INC. | $17.71 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sparrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.